Tiziana and Renaissance will partner to accelerate clinical development and potential commercial launch of nasal foralumab.

Long COVID is a complex and often debilitating complication following COVID-19 infection. It affects millions worldwide, presenting with symptoms such as persistent fatigue, cognitive impairment ...

H1N1 Vaccines Market H1N1 Vaccines Market Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "H1N1 Vaccines Market Analysis by ...

In a recent publication in Cell, researchers from the National University of Singapore and collaborators have proposed using commensal bacteria in the nasal cavity as a delivery vector for precision ...

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions, today announced its participation at the Emergencies ...

About 45% of children who receive intranasal midazolam for laceration repair do not respond to the medication and demonstrate ...

Alternative dosing routes, such as rectal and intranasal (IN) routes, have been suggested as options for oral or intravenous administration. Rhinitis and pharmacological agents used for treatment ...

The following is a summary of “Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V ...

has entered into a product development services agreement with Renaissance Lakewood LLC to enhance and scale up the formulation of its lead candidate, intranasal foralumab, a fully human anti-CD3 ...

Oragenics (OGEN) announced its participation at the Emergencies in Medicine Conference, where Dr. James Kelly, Chief Medical Officer and ...

More information: Kristy K L Coleman et al, Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive ...

View Full Profile. Learn about our Editorial Policies. With rare exceptions like the oral polio vaccine and intranasal vaccines against influenza, the majority of immunizations are administered ...